JP2012503985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012503985A5 JP2012503985A5 JP2011529281A JP2011529281A JP2012503985A5 JP 2012503985 A5 JP2012503985 A5 JP 2012503985A5 JP 2011529281 A JP2011529281 A JP 2011529281A JP 2011529281 A JP2011529281 A JP 2011529281A JP 2012503985 A5 JP2012503985 A5 JP 2012503985A5
- Authority
- JP
- Japan
- Prior art keywords
- loci
- subject
- lupus
- variation
- prognosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10065908P | 2008-09-26 | 2008-09-26 | |
| US61/100,659 | 2008-09-26 | ||
| PCT/US2009/058478 WO2010036960A2 (en) | 2008-09-26 | 2009-09-25 | Methods for treating, diagnosing, and monitoring lupus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012503985A JP2012503985A (ja) | 2012-02-16 |
| JP2012503985A5 true JP2012503985A5 (enExample) | 2012-11-15 |
Family
ID=42060417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529281A Pending JP2012503985A (ja) | 2008-09-26 | 2009-09-25 | ループスの治療、診断、モニタリング方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100099101A1 (enExample) |
| EP (1) | EP2344674A4 (enExample) |
| JP (1) | JP2012503985A (enExample) |
| KR (1) | KR20110081161A (enExample) |
| CN (1) | CN102224258A (enExample) |
| AU (1) | AU2009296393A1 (enExample) |
| BR (1) | BRPI0913778A2 (enExample) |
| CA (1) | CA2736373A1 (enExample) |
| IL (1) | IL211462A0 (enExample) |
| MX (1) | MX2011003273A (enExample) |
| WO (1) | WO2010036960A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2690608C (en) * | 2007-05-21 | 2020-07-21 | Genentech, Inc. | Methods and compositions for identifying and treating lupus |
| EP3839068A3 (en) * | 2009-10-07 | 2021-10-20 | F. Hoffmann-La Roche AG | Methods for treating, diagnosing, and monitoring lupus |
| DK3202898T3 (en) | 2009-11-02 | 2019-01-14 | Univ Washington | THERAPEUTIC NUCLEASE COMPOSITIONS AND PROCEDURES |
| CN102465170A (zh) * | 2010-11-05 | 2012-05-23 | 复旦大学附属华山医院 | 一种检测bank1基因单核苷酸多态性的方法 |
| AU2012214417A1 (en) * | 2011-02-10 | 2013-09-05 | Genqual Corporation | Methods of prognosing and administering treatment for inflammatory disorders |
| PH12013502441B1 (en) | 2011-04-29 | 2019-02-08 | Univ Washington | Therapeutic nuclease compositions and methods |
| CN102360016A (zh) * | 2011-07-21 | 2012-02-22 | 南京工业大学 | 流式微球法对SLE的Sm-RNP抗体检测试剂盒的制备 |
| RU2015113348A (ru) * | 2012-10-08 | 2016-11-27 | Ф. Хоффманн-Ля Рош Аг | Проникающие в клетки пептиды, связывающие интерферон-регулирующий фактор 5 |
| WO2014058254A1 (ko) * | 2012-10-10 | 2014-04-17 | 가톨릭대학교 산학협력단 | １ｑ２５．１(RABGAP1L) 위치, 6P21.32 (C4) 위치 및 １０ｑ２１．３위치의 ＤＮＡ 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물 |
| KR101491214B1 (ko) * | 2012-10-10 | 2015-02-06 | 가톨릭대학교 산학협력단 | １ｑ２５．１(RABGAP1L) 위치, 6p21.32 (C4) 위치 및 １０ｑ２１．３위치의 ＤＮＡ 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물 |
| CN111965358A (zh) * | 2013-02-08 | 2020-11-20 | 阿勒格尼-辛格研究所 | 细胞结合的补体激活产物作为狼疮前期诊断性生物标志物 |
| US20140278133A1 (en) * | 2013-03-15 | 2014-09-18 | Advanced Throughput, Inc. | Systems and methods for disease associated human genomic variant analysis and reporting |
| CN103397103B (zh) * | 2013-08-26 | 2016-04-20 | 中国人民解放军第三军医大学第三附属医院 | 一种检测socs家族基因标签单核甘酸多态性位点的方法及试剂盒 |
| SI3063275T1 (sl) | 2013-10-31 | 2020-02-28 | Resolve Therapeutics, Llc | Terapevtske fuzije nukleaza-albumin in postopki |
| EP2886140A1 (en) | 2013-12-17 | 2015-06-24 | University of Limerick | An apparatus for the extracorporeal treatment of blood |
| US20170269075A1 (en) * | 2014-05-12 | 2017-09-21 | Biogen Ma Inc. | Biomarkers predictive of lupus progression and uses thereof |
| AU2017290389B2 (en) | 2016-07-01 | 2024-09-26 | Resolve Therapeutics, Llc | Optimized binuclease fusions and methods |
| US10947295B2 (en) | 2017-08-22 | 2021-03-16 | Sanabio, Llc | Heterodimers of soluble interferon receptors and uses thereof |
| JP2024536558A (ja) * | 2021-10-18 | 2024-10-04 | カーステン マニュファクチュアリング コーポレーション | ゴルフクラブセンサハウジング |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022476B2 (en) * | 2002-02-26 | 2006-04-04 | New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery | Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof |
| US20070269827A1 (en) * | 2006-05-18 | 2007-11-22 | Oklahoma Medical Research Foundation | Predicting and Diagnosing Patients With Autoimmune Disease |
| CA2690608C (en) * | 2007-05-21 | 2020-07-21 | Genentech, Inc. | Methods and compositions for identifying and treating lupus |
| EP2403959A1 (en) * | 2009-03-03 | 2012-01-11 | Merck Serono S.A. | Bank1 related snps and sle and/or ms susceptibility |
-
2009
- 2009-09-25 AU AU2009296393A patent/AU2009296393A1/en not_active Abandoned
- 2009-09-25 EP EP09816951A patent/EP2344674A4/en not_active Withdrawn
- 2009-09-25 BR BRPI0913778A patent/BRPI0913778A2/pt not_active IP Right Cessation
- 2009-09-25 MX MX2011003273A patent/MX2011003273A/es unknown
- 2009-09-25 CN CN200980146949XA patent/CN102224258A/zh active Pending
- 2009-09-25 JP JP2011529281A patent/JP2012503985A/ja active Pending
- 2009-09-25 CA CA2736373A patent/CA2736373A1/en not_active Abandoned
- 2009-09-25 US US12/567,669 patent/US20100099101A1/en not_active Abandoned
- 2009-09-25 KR KR1020117006867A patent/KR20110081161A/ko not_active Withdrawn
- 2009-09-25 WO PCT/US2009/058478 patent/WO2010036960A2/en not_active Ceased
-
2011
- 2011-02-28 IL IL211462A patent/IL211462A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010528590A5 (enExample) | ||
| CN107475371B (zh) | 发现药物基因组生物标志物的方法 | |
| JP2014533949A5 (enExample) | ||
| Ruggiero et al. | Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms | |
| JP2009509508A5 (enExample) | ||
| JP2018038436A5 (enExample) | ||
| JP2011520433A5 (enExample) | ||
| JP2011528903A5 (enExample) | ||
| RU2009147281A (ru) | Способы и композиции для диагностики и лечения волчанки | |
| JP2013507127A5 (enExample) | ||
| RU2018122965A (ru) | Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания | |
| JP2013544536A5 (enExample) | ||
| RU2016131167A (ru) | Способы лечения, диагностики и мониторинга волчанки | |
| WO2011020906A3 (en) | sPLA2 IIA POLYMORPHISM ANALYSIS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT | |
| JP2006521812A5 (enExample) | ||
| WO2011088306A1 (en) | Methods of using genetic variants to diagnose crohn's disease | |
| CN106834501A (zh) | 与中国儿童肥胖相关的单核苷酸多态性位点及其应用 | |
| JP2016512950A (ja) | 抗精神病薬に基づく処置により誘導される錐体外路症状（ｅｐｓ）の発症を予測する方法 | |
| EP3315613B1 (en) | Methods and kits for diagnosing or assessing the risk of cervical cancer | |
| KR101724130B1 (ko) | 장 베체트병 진단용 바이오마커 및 이의 용도 | |
| CN103589795B (zh) | 一种检测与肺癌易感性及化疗敏感性相关基因的多态性的试剂盒及其应用 | |
| CN109913552B (zh) | 一种食管鳞癌诊疗靶点及应用 | |
| KR101598328B1 (ko) | Dna 복제수 변이를 이용한 강직성 척추염 발병 저위험도 예측용 조성물 및 이를 이용한 예측 방법 | |
| WO2015168252A1 (en) | Mitochondrial dna copy number as a predictor of frailty, cardiovascular disease, diabetes, and all-cause mortality | |
| KR101617612B1 (ko) | 한국인의 고혈압 예측용 ｓｎｐ 마커 |